ADME Study of [14C] Antaitavir Hasophate in Healthy Male Subjects

Clinical trial NCT05446233 · COMPLETED

Trial details

NCT number: NCT05446233
Sponsor: Sunshine Lake Pharma Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Male Subjects

Start date: 2022-11-15
Primary completion: 2023-01-02
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.